Evogene (EVGN) Company Presentation summary

Vision and mission

• Aims to pioneer groundbreaking life-science products rooted in microbes, small molecules, and genomics, merging scientific expertise with AI and big data technologies for discovery and optimization.

• Focuses on accelerating and optimizing life-science product development through three dedicated AI tech engines: ChemPass AI, MicroBoost AI, and GeneRator AI.

• Targets diverse industries including agriculture, food, pharma, wellness, and environmental solutions.

Technology and product development

• AI tech engines enable computational selection and optimization of candidates, increasing probability of success and reducing time and cost.

• Collaboration with Google Cloud resulted in a foundation model for small-molecule design, achieving 90% precision in novel molecule generation.

• Proprietary platforms support product pipelines in microbials, small molecules, and genetic elements.

Business strategy and model

• Captures value through collaborative partnerships and licensing, leveraging partners' field expertise for innovation and financial gains.

• Two main partnership structures: licensing (time-limited tech engine use) and collaboration (joint development and commercialization).

• Revenue streams include license fees, R&D reimbursements, royalties, dividends, upfront payments, and milestone payments.